Literature DB >> 7507977

Differential expression of tenascin after denervation, damage or paralysis of mouse soleus muscle.

A Irintchev1, T F Salvini, A Faissner, A Wernig.   

Abstract

The expression of the extracellular matrix molecule tenascin was studied by immunocytochemistry and Western blotting in soleus muscles of adult mice after nerve damage (denervation), muscle injury (induced by enforced running or freezing) and functional block of synaptic transmission (botulinum toxin). Enhanced expression of tenascin in the extracellular spaces around focally damaged muscle fibres was found already 10 h after onset of running on a motor-driven treadmill which causes muscle injury in soleus muscle. Tenascin expression reached a peak at 2-3 days post-exercise, after which it declined gradually and became undetectable by two weeks after injury. Similarly, cryo-damage of soleus muscles in situ led to upregulation of tenascin. Chronic muscle denervation after sciatic nerve transection caused a persistent (studied up to 31 days) expression of tenascin at denervated endplates and in intramuscular nerve branches but not in other tissue compartments. Local application of botulinum toxin Type A, which results in muscle inactivity but not in tissue degeneration, however, did not induce tenascin expression 12 h to 12 days post-injection. Expression of tenascin after denervation and muscle damage, but its absence after paralysis, were verified by SDS-PAGE and Western blot analysis. Independent of the type of injury (muscle, nerve or both) the known major isoforms of mouse tenascin, as judged by M(r) comparison, were re-expressed, with no preponderance of individual M(r) forms. These results show that tenascin expression in adult muscles is induced by both axon and muscle fibre damage but not by muscle inactivity. In contrast, NCAM, in accordance with previous observations, showed enhanced expression both as a result of inactivity and in association with tissue repair.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507977     DOI: 10.1007/bf01218353

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  13 in total

1.  Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles.

Authors:  A Wernig; M Zweyer; A Irintchev
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

2.  Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts.

Authors:  A Irintchev; M Langer; M Zweyer; R Theisen; A Wernig
Journal:  J Physiol       Date:  1997-05-01       Impact factor: 5.182

3.  The extracellular matrix glycoprotein tenascin-C is beneficial for spinal cord regeneration.

Authors:  Jian Chen; Hyun Joon Lee; Igor Jakovcevski; Ronak Shah; Neha Bhagat; Gabriele Loers; Hsing-Yin Liu; Sally Meiners; Grit Taschenberger; Sebastian Kügler; Andrey Irintchev; Melitta Schachner
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

4.  Immunolocalization of tenascin-C in human type II fiber atrophy.

Authors:  B G Schoser; A Faissner; H H Goebel
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

5.  Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy.

Authors:  A P Kvist; A Latvanlehto; M Sund; L Eklund; T Väisänen; P Hägg; R Sormunen; J Komulainen; R Fässler; T Pihlajaniemi
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression.

Authors:  A Wernig; A Irintchev; G Lange
Journal:  J Physiol       Date:  1995-04-15       Impact factor: 5.182

7.  Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons.

Authors:  B Götz; A Scholze; A Clement; A Joester; K Schütte; F Wigger; R Frank; E Spiess; P Ekblom; A Faissner
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

8.  Analyses of the differentiation potential of satellite cells from myoD-/-, mdx, and PMP22 C22 mice.

Authors:  Marion M Schuierer; Christopher J Mann; Heidi Bildsoe; Clare Huxley; Simon M Hughes
Journal:  BMC Musculoskelet Disord       Date:  2005-03-11       Impact factor: 2.362

Review 9.  Molecular mechanisms of treadmill therapy on neuromuscular atrophy induced via botulinum toxin A.

Authors:  Sen-Wei Tsai; Hsiao-Ling Chen; Yi-Chun Chang; Chuan-Mu Chen
Journal:  Neural Plast       Date:  2013-11-12       Impact factor: 3.599

10.  Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca(2+) release channel.

Authors:  Dilyana Filipova; Anna M Walter; John A Gaspar; Anna Brunn; Nina F Linde; Mostafa A Ardestani; Martina Deckert; Jürgen Hescheler; Gabriele Pfitzer; Agapios Sachinidis; Symeon Papadopoulos
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.